Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
16-30
Author(s):
R. Deane, R. D. Bell, A. Sagare and B. V. Zlokovic
Quantitative and Mechanistic Studies of Aβ Immunotherapy
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
31-49
Author(s):
Todd E. Golde, Pritam Das and Yona Levites
Immunotherapy, Vascular Pathology, and Microhemorrhages in Transgenic Mice
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
50-64
Author(s):
Donna M. Wilcock and Carol A. Colton
Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
65-81
Author(s):
Mary P. Lambert, Pauline T. Velasco, Kirsten L. Viola and William L. Klein
Antibody Responses, Amyloid-β Peptide Remnants and Clinical Effects of AN-1792 Immunization in Patients with AD in an Interrupted Trial
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
88-97
Author(s):
Tyler A. Kokjohn and Alex E. Roher
Immunotherapy in a Natural Model of Aβ Pathogenesis: The Aging Beagle
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
98-113
Author(s):
Vitaly Vasilevko and Elizabeth Head
Alternative Aβ Immunotherapy Approaches for Alzheimers Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
114-127
Author(s):
Terrence Town
Rationale for Peptide and DNA Based Epitope Vaccines for Alzheimers Disease Immunotherapy
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
128-143
Author(s):
Anahit Ghochikyan
Critical Issues for Successful Immunotherapy in Alzheimers Disease: Development of Biomarkers and Methods for Early Detection and Intervention
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
144-159
Author(s):
Rawan Tarawneh and David M. Holtzman
AD Vaccines: Conclusions and Future Directions
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
160-166
Author(s):
Thomas Wisniewski